NCT06079112 2024-09-199MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial CancerMabwell (Shanghai) Bioscience Co., Ltd.Phase 1/2 Recruiting100 enrolled